GLOBAL NEXT-GENERATION BIOLOGICS MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Jan 2019 118

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Next generation biologics refers to some noval drugs, biotreatment and some breakthroght biomaterials etc.

Scope of the Report:
This report studies the Next-Generation Biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Next-Generation Biologics market by product type and applications/end industries.
The increasing demand for antibody drug conjugates (ADCs) is one of the major factors driving this market’s growth. ADCs are highly effective cytotoxic drugs linked to an mAbs. These drugs have shown to be potent and efficient in treating diseases, including cancers and hematological malignancies.
The global Next-Generation Biologics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Next-Generation Biologics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
- Allergan
- Bayer
- Biogen Idec
- Eli Lilly
- Kyowa Hakko Kirin
- Molecular Partners
- Novo Nordisk
- Pfizer
- Roche
- Sanofi

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Antibodies
- Regenerative medicine
- Insulins
- Growth hormones
- Other

Market Segment by Applications, can be divided into
- Medical
- Scientific Research
- Other

Table of Contents

Related reports :

(Mar 19)

Glycoproteins are proteins that contain oligosaccharide chains (glycans) covalently attached to polypeptide side-chains. The carbohydrate is...

(Mar 19)

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both ...

(Mar 19)

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an o...

(Mar 19)

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one...

(Mar 19)

The global market is further analyzed by the following types: DNA microarray, flow cytometry, liquid chromatography, membrane filtration, pr...

(Mar 19)

A 3D cell culture is an artificially-created environment in which biological cells are permitted to grow or interact with their surroundings...

GLOBAL NEXT-GENERATION BIOLOGICS MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Biotechnology market as per your needs. Get the best of Biotechnology research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy